Ultraviolet light is generally recognized by the common people as the cause of various diseases of the skin such as melanoma and other skin complaints caused by allergies such as skin cosmetics blackened, shriveled, etc. Ultraviolet light from the sun is a component that is not visible to the eye. However, ultraviolet apparently not only has a negative impact on health, but also beneficial for the treatment of vitiligo disease. Vitiligo is a skin disease characterized by white lesions is not pigmented skin due to loss of function of melanocytes. The prevalence of vitiligo is quite high, ranging between 0,1%-2% of the entire population of the world. Latest therapies in vitiligo developed using Narrowband UV-B is Ultraviolet B (NB-UVB). Recent classification of vitiligo is divided into two types: segmental (type B) and no segmental (Type A). Type B is rarer and has a dermatome distribution, after experiencing a rapid onset and progression, usually have a disease that is more stable. A more common type, and has the potential evolution of life, and is associated with Keener phenomenon and is often associated with autoimmune diseases such as thyroid disorders, type 1 diabetes mellitus, pernicious anemia, and Addison’s disease.
NB-UVB therapy using an ultraviolet lamp with emission maximum of 311 nm. Currently, NB-UVB is the first choice therapy in this disease because it is safe and effective in children and adult patients with generalized vitiligo. UVB has immunomodulatory effects that can stabilize the abnormal immune response in patients with vitiligo. Stimulation of follicular melanocytes occurs because NB-UVB activates the inactive melanocytes in the hair follicle outer root Seath in the middle and bottom. Melanosomal protein inactive melanocytes but does not have the enzymes needed for melanogenesis. For more information on the healing of skin diseases using modern tools and ultraviolet light, please read the article on the site located at http://uvb-lamps.com/about/.